⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16144917 | 1.00 | — | — | |
| SCHEMBL2002186 | 1.00 | — | — | |
| SCHEMBL15697283 | 0.76 | — | — | |
| SCHEMBL15402934 | 0.76 | — | — | |
| SCHEMBL12915127 | 0.74 | — | — | |
| SCHEMBL2608633 | 0.73 | — | — | |
| SCHEMBL22103917 | 0.73 | — | — | |
| SCHEMBL1469570 | 0.73 | — | — | |
| SCHEMBL12290757 | 0.73 | — | — | |
| SCHEMBL256676 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 941 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11345693-B2 | Compounds, salts thereof and methods for treatment of diseases | ACADIA PHARMACEUTICALS INC. (US) | 2022-05-31 | — | — | US | claimed |
| US-20210122713-A1 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | ACADIA PHARMACEUTICALS INC. (US) | 2021-04-29 | — | — | US | claimed |
| US-20200270239-A1 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | ACADIA PHARMACEUTICALS INC. (US) | 2020-08-27 | — | — | US | claimed |
| EP-3672954-A1 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | Acadia Pharmaceuticals Inc. (US) | 2020-07-01 | — | — | EP | claimed |
| EP-3672960-A2 | COMPOUNDS, SALTS THEREOF AND THEIR USE FOR THE TREATMENT OF DISEASES | Acadia Pharmaceuticals Inc. (US) | 2020-07-01 | — | — | EP | claimed |
| CN-111132976-A | Compounds, salts thereof and methods for treating diseases | 阿卡蒂亚药品公司 | 2020-05-08 | — | — | CN | claimed |
| CN-111013338-A | Drying method of halogenated hydrocarbon | 北京诺维新材科技有限公司 | 2020-04-17 | — | — | CN | claimed |
| US-20190071544-A1 | NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION | BASF SOUTH EAST ASIA PTE. LTD. (SG) | 2019-03-07 | — | — | US | claimed |
| WO-2019040105-A2 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | ACADIA PHARMACEUTICALS INC. (US) | 2019-02-28 | — | — | WO | claimed |
| WO-2019040107-A1 | COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES | ACADIA PHARMACEUTICALS INC. (US) | 2019-02-28 | — | — | WO | claimed |
| WO-2006009980-A2 | OLEFIN POLYMERISATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-01-26 | — | — | WO | claimed |
| WO-2006009550-A1 | METHODS FOR SEPARARING SLURRY COMPONENTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-01-26 | — | — | WO | claimed |
| EP-1572751-A2 | POLYMERIZATION PROCESSES | ExxonMobil Chemical Patents Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| EP-1572753-A1 | POLYMERIZATION PROCESSES | ExxonMobil Chemical Patents Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| US-20050107536-A1 | Polymers with new sequence distributions | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-05-19 | — | — | US | claimed |
| US-20050101751-A1 | Halogenated polymers with new sequence distributions | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-05-12 | — | — | US | claimed |
| WO-2004067577-A2 | POLYMERIZATION PROCESSES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-08-12 | — | — | WO | claimed |
| WO-2004058829-A1 | POLYMERIZATION PROCESSES | EXXONMOBIL CHEMICAL PATENTS, INC. (US) | 2004-07-15 | — | — | WO | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |